If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPinewood Technologies Group Regulatory News (PINE)

Share Price Information for Pinewood Technologies Group (PINE)

Share Price is delayed by 15 minutes
Get Live Data
300.00    -4.50 (-1.48%)
Bid:
298.50
Ask:
300.00
Spread: 1.50 (0.503%)
Market Cap: £345.29m
PINE Live PriceLast checked at - London Stock Exchange

Intraday Pinewood Technologies Group Share Chart

Form 8.3 - Pinewood Technologies Group plc

10 Feb 2026 15:07

Newtyn Management LLC - Form 8.3 - Pinewood Technologies Group plc

Newtyn Management LLC - Form 8.3 - Pinewood Technologies Group plc

PR Newswire

LONDON, United Kingdom, February 10

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: Newtyn Management, LLC
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Pinewood Technologies Group plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure February 9, 2026
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A” N/A

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: 100p ordinary
Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled: 6,324,512 5.49%
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
TOTAL: 6,324,512 5.49%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security Purchase/sale Number of securities Price per unit
100p ordinary Purchase 60,512 GBP 4.518

(b) Cash-settled derivative transactions

Class of relevant security Product description e.g. CFD Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position Number of reference securities Price per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type e.g. American, European etc. Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description e.g. call option Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing e.g. subscription, conversion Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? No
Date of disclosure: February 10, 2026
Contact name: Nazim Ally
Telephone number*: 212-446-2460

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.



Date   Source Headline
3rd Nov 20257:00 amRNSHolding(s) in Company*
20th Oct 20257:00 amRNSNotification pursuant to UKLR 6.4.8
14th Oct 20257:00 amRNSDirectorate Changes
25th Sep 20254:12 pmRNSDirector/PDMR Shareholding
25th Sep 202512:13 pmRNSHolding(s) in Company
24th Sep 20257:00 amRNSHalf year results for the 6 months to 30 June 2025
15th Sep 20257:00 amRNSInclusion in FTSE 250 Index
11th Sep 20256:00 pmRNSWarehouse REIT
26th Aug 20255:26 pmRNSDirector/PDMR Shareholding
20th Aug 20257:00 amRNSHolding(s) in Company
4th Aug 202512:00 pmRNSCompletion of PWSA Business Acquisition
4th Aug 202511:41 amRNSHolding(s) in Company
4th Aug 20257:00 amRNSNotice of Interim Results
1st Aug 20259:00 amRNSHolding(s) in Company
31st Jul 20258:03 amRNSCompletion of Lithia JV Acquisition & Admission
30th Jul 20252:00 pmRNSAdmission of New Ordinary Shares
28th Jul 20257:00 amRNSAmendment of Acquisition Agreement
25th Jul 20253:35 pmRNSDirector/PDMR Shareholding
7th Jul 202511:28 amRNSDirector/PDMR Shareholding
7th Jul 20257:00 amRNSAcquisition of Pinewood South Africa Business
1st Jul 20253:23 pmRNSHolding(s) in Company
30th Jun 20254:10 pmRNSResults of AGM & General Meeting
27th Jun 20254:13 pmRNSDirector/PDMR Shareholding
12th Jun 20252:40 pmRNSDirector/PDMR Shareholding
6th Jun 20253:38 pmRNSPublication of Prospectus
6th Jun 20257:00 amRNSAcquisition of Lithia’s Stake in North America JV
4th Jun 202512:00 pmRNSBoard composition update
28th May 20257:00 amRNSDirector/PDMR Shareholding
29th Apr 20257:00 amRNSSignificant New Contract Award
28th Apr 20252:51 pmRNSDirector/PDMR Shareholding
17th Apr 202511:29 amRNSPublication of the Annual Report & Accounts FY24
1st Apr 20257:00 amRNSFinal Results
28th Mar 20259:00 amRNSDirector Declaration
28th Mar 20259:00 amRNSDirector/PDMR Shareholding
20th Mar 20254:24 pmRNSNotice of Results
3rd Mar 20252:00 pmRNSIssue of Seez Consideration Shares
27th Feb 20257:00 amRNSDirector/PDMR Shareholding
25th Feb 20251:54 pmRNSDirector/PDMR Shareholding
25th Feb 202512:00 pmRNS-RCommencement of Trading on OTCQX in the U.S.
21st Feb 20257:00 amRNSResult of Equity Fundraise
20th Feb 20254:40 pmRNSRetailBook Offer
20th Feb 20254:36 pmRNSEquity Fundraise
20th Feb 20254:35 pmRNSProposed Acquisition of Seez
14th Feb 20257:00 amRNSSignificant New Contract Award and Trading Update
12th Feb 202511:10 amRNSHolding(s) in Company
28th Jan 202512:09 pmRNSDirector/PDMR Shareholding
30th Dec 20247:00 amRNSPDMR Transaction Notification
20th Dec 20244:46 pmRNSHolding(s) in Company
26th Nov 202412:02 pmRNSDirector/PDMR Shareholding
22nd Nov 202411:45 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.